PsychoGenics Inc.

Industry

  • Services
  • Pharmaceuticals
  • Biotechnology
    • Transgenics
    • Drug Discovery Technologies
      • Bioinformatics
      • Genomics-Proteomics
      • ADMET
  • Contract Research Organization-CRO
See more in Biomedtracker

Latest on PsychoGenics Inc.

Scrip

Sumitomo Pharma To Cut 400 US Employees Amid Latuda LOE

 
• By Lisa Takagi

Sumitomo Pharma Co., Ltd. has decided to cut another 400 employees at its US subsidiary Sumitomo Pharma America, Inc. (SPMA) after already reducing headcount there by 500 in an earlier reorganization

Scrip

Ulotaront Phase III Schizophrenia Setback For Sumitomo, Otsuka Alliance

 
• By Ian Haydock

Sumitomo Pharma Co., Ltd. and Otsuka Pharmaceutical Co. Ltd. ’s ulotaront (SEP-363856) has failed in two Phase III trials for severe schizophrenia, posing a setback for the multi-product CNS allianc

Scrip

Deal Watch: Aging-Focused Calico Taps Start-Up Terray For Discovery

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Terray Inks Initial Partnership With Ca

Scrip

Deal Watch: AbbVie Exits Inherited CRISPR-Cas9 Team-Up With Editas

 
• By Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AbbVie Opts Not To Continue Leber Conge